Top compounds associated with response to TIGD2


Feature Type Standardized
Nominal ANOVA
mRNA BRD-A02303741:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.0002 1
mRNA Vandetanib CTRPv2 pan-cancer AAC 0.0002 1
mRNA Bosutinib CTRPv2 pan-cancer AAC 2.9e-05 1
mRNA BRD-K55473186 CTRPv2 pan-cancer AAC -3.6e-05 1
Download CSV